Short-range interactions between fibrocytes and CD8+ T cells in COPD bronchial inflammatory response
E. Eyraud, E. Maurat, J.-M. Sac-Epee, P. Henrot, M. Zysman, P. Esteves, T. Trian, J.-W. Dupuy, A. Leipold, A.-E. Saliba, H. Begueret, P.-O. Girodet, M. Thumerel, R. Hustache-Castaing, R. Marthan, F. Levet, P. Vallois, C. Contin-Bordes, P. Berger, I. Dupin
Abstract
AbstractBronchi of chronic obstructive pulmonary disease (COPD) are the site of extensive cell infiltration, allowing persistent contacts between resident cells and immune cells. Tissue fibrocytes interaction with CD8+ T cells and its consequences were investigated using a combination of in situ, in vitro experiments and mathematical modeling. We show that fibrocytes and CD8+ T cells are found in vicinity in distal airways and that potential interactions are more frequent in tissues from COPD patients compared to those of control subjects. Increased proximity and clusterization between CD8+ T cells and fibrocytes are associated with altered lung function. Tissular CD8+ T cells from COPD patients promote fibrocyte chemotaxis via the CXCL8-CXCR1/2 axis. Live imaging shows that CD8+ T cells establish short-term interactions with fibrocytes, that trigger CD8+ T cell proliferation in a CD54- and CD86-dependent manner, pro-inflammatory cytokines production, CD8+ T cell cytotoxic activity against bronchial epithelial cells and fibrocyte immunomodulatory properties. We defined a computational model describing these intercellular interactions and calibrated the parameters based on our experimental measurements. We show the models ability to reproduce histological ex vivo characteristics, and observe an important contribution of fibrocyte-mediated CD8+ T cell proliferation in COPD development. Using the model to test therapeutic scenarios, we predict a recovery time of several years, and the failure of targeting chemotaxis or interacting processes. Altogether, our study reveals that local interactions between fibrocytes and CD8+ T cells could jeopardize the balance between protective immunity and chronic inflammation in bronchi of COPD patients.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Fibrocyte accumulation in bronchi: a cellular hallmark of COPD
Isabelle Dupin, Matthieu Thumerel, … Patrick Berger·bioRxiv·Oct 23, 2018
- T-cell Multiomic Analysis Identifies Subsets and Mechanisms of Interaction with Epithelial Cells in Idiopathic Pulmonary Fibrosis
Ana Paula Moreira Serezani, Júlia Miranda Ribeiro Bazzano, … Timothy S. Blackwell·bioRxiv·Nov 19, 2025
- Imbalance between IL-36 receptor agonist and antagonist drives neutrophilic inflammation in COPD
J. R. Baker, P. S. Fenwick, … L. E. Donnelly·bioRxiv·Oct 6, 2021
- CXCR4 blockade alleviates pulmonary and cardiac outcomes in early COPD
I. Dupin, P. Henrot, … P. Berger·American Journal of Respiratory Cell and Molecular BiologyPeer-reviewed·Oct 1, 2025
- Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19
H. Narasimhan, I. S. Cheon, … J. Sun·bioRxiv·Sep 13, 2023
- Systemic Markers of Adaptive and Innate Immunity Are Associated with COPD Severity and Spirometric Disease Progression
Eitan Halper‐Stromberg, Jeong Hyun Yun, … Peter J. Castaldi·American Journal of Respiratory Cell and Molecular BiologyPeer-reviewed·Dec 5, 2017